207 related articles for article (PubMed ID: 32122211)
1. Inhibition of histone demethylase JMJD1C attenuates cardiac hypertrophy and fibrosis induced by angiotensin II.
Zhang S; Lu Y; Jiang C
J Recept Signal Transduct Res; 2020 Aug; 40(4):339-347. PubMed ID: 32122211
[TBL] [Abstract][Full Text] [Related]
2. Histone lysine dimethyl-demethylase KDM3A controls pathological cardiac hypertrophy and fibrosis.
Zhang QJ; Tran TAT; Wang M; Ranek MJ; Kokkonen-Simon KM; Gao J; Luo X; Tan W; Kyrychenko V; Liao L; Xu J; Hill JA; Olson EN; Kass DA; Martinez ED; Liu ZP
Nat Commun; 2018 Dec; 9(1):5230. PubMed ID: 30531796
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-(1-7) attenuates angiotensin II-induced cardiac hypertrophy via a Sirt3-dependent mechanism.
Guo L; Yin A; Zhang Q; Zhong T; O'Rourke ST; Sun C
Am J Physiol Heart Circ Physiol; 2017 May; 312(5):H980-H991. PubMed ID: 28411231
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-92b-3p suppresses angiotensin II-induced cardiomyocyte hypertrophy via targeting HAND2.
Yu XJ; Huang YQ; Shan ZX; Zhu JN; Hu ZQ; Huang L; Feng YQ; Geng QS
Life Sci; 2019 Sep; 232():116635. PubMed ID: 31283925
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of farnesyl pyrophosphate synthase attenuates angiotensin II-induced cardiac hypertrophy and fibrosis in vivo.
Yang J; Zhu HH; Chen GP; Ye Y; Zhao CZ; Mou Y; Hu SJ
Int J Biochem Cell Biol; 2013 Mar; 45(3):657-66. PubMed ID: 23277274
[TBL] [Abstract][Full Text] [Related]
6. CD38 promotes angiotensin II-induced cardiac hypertrophy.
Guan XH; Hong X; Zhao N; Liu XH; Xiao YF; Chen TT; Deng LB; Wang XL; Wang JB; Ji GJ; Fu M; Deng KY; Xin HB
J Cell Mol Med; 2017 Aug; 21(8):1492-1502. PubMed ID: 28296029
[TBL] [Abstract][Full Text] [Related]
7. The Histone Demethylase JMJD1C Regulates CAMKK2-AMPK Signaling to Participate in Cardiac Hypertrophy.
Yu S; Li Y; Zhao H; Wang Q; Chen P
Front Physiol; 2020; 11():539. PubMed ID: 32625104
[TBL] [Abstract][Full Text] [Related]
8. Sodium butyrate attenuates angiotensin II-induced cardiac hypertrophy by inhibiting COX2/PGE2 pathway via a HDAC5/HDAC6-dependent mechanism.
Zhang L; Deng M; Lu A; Chen Y; Chen Y; Wu C; Tan Z; Boini KM; Yang T; Zhu Q; Wang L
J Cell Mol Med; 2019 Dec; 23(12):8139-8150. PubMed ID: 31565858
[TBL] [Abstract][Full Text] [Related]
9. Novel EGFR inhibitors attenuate cardiac hypertrophy induced by angiotensin II.
Peng K; Tian X; Qian Y; Skibba M; Zou C; Liu Z; Wang J; Xu Z; Li X; Liang G
J Cell Mol Med; 2016 Mar; 20(3):482-94. PubMed ID: 26762600
[TBL] [Abstract][Full Text] [Related]
10. C1QTNF1 attenuates angiotensin II-induced cardiac hypertrophy via activation of the AMPKa pathway.
Wu L; Gao L; Zhang D; Yao R; Huang Z; Du B; Wang Z; Xiao L; Li P; Li Y; Liang C; Zhang Y
Free Radic Biol Med; 2018 Jun; 121():215-230. PubMed ID: 29733904
[TBL] [Abstract][Full Text] [Related]
11. miR-34a modulates angiotensin II-induced myocardial hypertrophy by direct inhibition of ATG9A expression and autophagic activity.
Huang J; Sun W; Huang H; Ye J; Pan W; Zhong Y; Cheng C; You X; Liu B; Xiong L; Liu S
PLoS One; 2014; 9(4):e94382. PubMed ID: 24728149
[TBL] [Abstract][Full Text] [Related]
12. Promyelocytic leukemia zinc finger protein activates GATA4 transcription and mediates cardiac hypertrophic signaling from angiotensin II receptor 2.
Wang N; Frank GD; Ding R; Tan Z; Rachakonda A; Pandolfi PP; Senbonmatsu T; Landon EJ; Inagami T
PLoS One; 2012; 7(4):e35632. PubMed ID: 22558183
[TBL] [Abstract][Full Text] [Related]
13. BRD4 blockage alleviates pathological cardiac hypertrophy through the suppression of fibrosis and inflammation via reducing ROS generation.
Zhu W; Wu RD; Lv YG; Liu YM; Huang H; Xu JQ
Biomed Pharmacother; 2020 Jan; 121():109368. PubMed ID: 31707348
[TBL] [Abstract][Full Text] [Related]
14. EndophilinA2 protects against angiotensin II-induced cardiac hypertrophy by inhibiting angiotensin II type 1 receptor trafficking in neonatal rat cardiomyocytes.
Liu Y; Shen HJ; Wang XQ; Liu HQ; Zheng LY; Luo JD
J Cell Biochem; 2018 Nov; 119(10):8290-8303. PubMed ID: 29923351
[TBL] [Abstract][Full Text] [Related]
15. Klotho inhibits angiotensin II-induced cardiac hypertrophy, fibrosis, and dysfunction in mice through suppression of transforming growth factor-β1 signaling pathway.
Ding J; Tang Q; Luo B; Zhang L; Lin L; Han L; Hao M; Li M; Yu L; Li M
Eur J Pharmacol; 2019 Sep; 859():172549. PubMed ID: 31325434
[TBL] [Abstract][Full Text] [Related]
16. Bone morphogenetic protein-4 mediates cardiac hypertrophy, apoptosis, and fibrosis in experimentally pathological cardiac hypertrophy.
Sun B; Huo R; Sheng Y; Li Y; Xie X; Chen C; Liu HB; Li N; Li CB; Guo WT; Zhu JX; Yang BF; Dong DL
Hypertension; 2013 Feb; 61(2):352-60. PubMed ID: 23248151
[TBL] [Abstract][Full Text] [Related]
17. AR-negative prostate cancer is vulnerable to loss of JMJD1C demethylase.
Yoshihama Y; LaBella KA; Kim E; Bertolet L; Colic M; Li J; Shang X; Wu CJ; Spring DJ; Wang YA; Hart T; DePinho RA
Proc Natl Acad Sci U S A; 2021 Sep; 118(36):. PubMed ID: 34475205
[TBL] [Abstract][Full Text] [Related]
18. Targeting JMJD3 histone demethylase mediates cardiac fibrosis and cardiac function following myocardial infarction.
Long F; Wang Q; Yang D; Zhu M; Wang J; Zhu Y; Liu X
Biochem Biophys Res Commun; 2020 Aug; 528(4):671-677. PubMed ID: 32513540
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of myofibrillogenesis regulator-1 aggravates cardiac hypertrophy induced by angiotensin II in mice.
Li HL; She ZG; Li TB; Wang AB; Yang Q; Wei YS; Wang YG; Liu DP
Hypertension; 2007 Jun; 49(6):1399-408. PubMed ID: 17420335
[TBL] [Abstract][Full Text] [Related]
20. Vinpocetine Attenuates Pathological Cardiac Remodeling by Inhibiting Cardiac Hypertrophy and Fibrosis.
Wu MP; Zhang YS; Xu X; Zhou Q; Li JD; Yan C
Cardiovasc Drugs Ther; 2017 Apr; 31(2):157-166. PubMed ID: 28321644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
